Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 10

Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome

Total article views   Abstract views HTML views PDF downloads Totals
8,045 Dovepress* 6,390 1,011+ 1,691 7,401
PubMed Central* 0 644 319 644
Totals 6,390 1,655 2,010 8,045
*Since 27 January 2017
+Since July 2016

View citations on PubMed Central and Google Scholar